Abstract

BackgroundInfection prevention and control (IPC) is one of the most cost-effective interventions against antimicrobial resistance (AMR). Yet, IPC knowledge gaps often receive little prominence in AMR research agendas. In this article, we construct IPC research priorities, in order to draw attention to these critical research needs.MethodsWe developed a 4-step framework to identify IPC knowledge gaps from literature (narrative review). These gaps were then translated into research priorities and sent to two groups of European IPC experts for validation and critique through an online survey.ResultsSeventy-nine publications were retrieved from the literature review, identifying fifteen IPC research gaps. Forty-four IPC experts, clustered in two groups, vetted them. The experts classified all research gaps as medium or high priority. Overall agreement between both groups was average (Kendall’s τ = 0.43), with strong alignment on the highest priorities: (i) the assessment of organizational, socio-economic, and behavioural barriers/facilitators for the implementation of IPC programmes, (ii) the impact of overcrowding on the spread of infections and (iii) the impact of infrastructural changes, at facility level, on the reduction of infections. Feedback from experts also identified an additional research gap on the interaction between the human and hospital microbiomes.ConclusionsWe formulated a list of sixteen research priorities and identified three urgent needs. Now, we encourage researchers, funding agencies, policymakers and relevant stakeholders to start addressing the identified gaps.

Highlights

  • Antimicrobial resistance (AMR) is a growing health issue with the potential to undermine modern medicine

  • In 2015, 670,000 infections with antibiotic-resistant bacteria were reported in Europe accounting for 33,000 deaths [1]

  • Bacteria will always evolve resistance to antibiotics. This evolution can be hindered through a broad set of interventions combining surveillance, antibiotic stewardship, infection prevention and control (IPC) and ensuring appropriate access to antibiotics while maintaining efforts to bring new innovative antibiotics, diagnostics, and vaccines to the market [3]

Read more

Summary

Introduction

Antimicrobial resistance (AMR) is a growing health issue with the potential to undermine modern medicine. Bacteria will always evolve resistance to antibiotics This evolution can be hindered through a broad set of interventions combining surveillance, antibiotic stewardship, infection prevention and control (IPC) and ensuring appropriate access to antibiotics while maintaining efforts to bring new innovative antibiotics (or alternative therapeutics), diagnostics, and vaccines to the market [3]. All these interventions need to be applied in a One Health perspective, considering the interaction between humans, animals and the environment [4]. We construct IPC research priorities, in order to draw attention to these critical research needs

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call